معرفی
Professor Suresh Sundram is Head of the Department of Psychiatry at Monash University's School of Clinical Sciences and Director of Research at Monash Health's Mental Health Program. He holds a PhD in Psychiatry from the University of Melbourne (2001), following earlier degrees in Medicine (MBBS, 1988) and Psychiatry (MMed, 1999). His research focuses on molecular mechanisms underlying schizophrenia and related psychotic disorders, integrating pharmacological, neurochemical, and neuropathological approaches. Notable areas include treatment resistance, suicide neurobiology, and maternal immune activation effects on neurodevelopment. He leads over 19 active research projects, including biomarker identification and clinical trials in autism and psychosis. His work has produced >150 publications and contributes to UN Sustainable Development Goals on health and well-being. He serves as deputy editor for the Asian Journal of Psychiatry and advises UN agencies.
- Education: MBBS (1988), MMed (1999), PhD (2001) - University of Melbourne
- Expertise: Schizophrenia, Molecular Neuroscience, Refugee Health, Psychopharmacology
Recent research trends emphasize maternal-child health impacts of viral infections, neurodevelopmental mechanisms in autism, and translational research bridging molecular and clinical psychiatry. His articles analyze epigenetic changes, immune system interactions, and novel therapeutic targets like NMDA receptor subunits. Projects include global collaborations on psychedelic medicine and preterm birth interventions.
He advises governmental bodies and international organizations on mental health policy, particularly regarding refugee populations. Current grants include a Phase 2 trial evaluating cannabidiol for autism and biomarker development for early psychosis.
